Division of Spine, Department of Orthopaedics, University of British Columbia, Vancouver, BC, Canada.
J Rehabil Med. 2010 Sep;42(8):724-34. doi: 10.2340/16501977-0584.
To evaluate and compare the construct validity of 5 participation instruments developed using the International Classification of Functioning, Disability and Health (ICF).
A total of 545 subjects diagnosed and treated for a spinal condition at an acute hospital were followed-up and consented to complete a questionnaire. Subjects completed 5 participation instruments (Impact on Participation and Autonomy (IPA), Keele Assessment of Participation (KAP), Participation Measure-Post Acute Care (PM-PAC), Participation Objective Participation Subjective (POPS), World Health Organization Disability Assessment Schedule II (WHODAS II)). In addition, each subject completed a health status instrument and a quality of life instrument. The dimensionality, convergent/discriminant validity and known-group validity of the participation instruments were assessed.
A confirmatory factor analysis of the facture structure for the IPA and PM-PAC demonstrated adequate model fit. For convergent/discriminant validity, correlations were generally higher among similar domains of the WHODAS II, IPA, KAP and PM-PAC, and as expected the lowest correlations were observed with the objective domains of the POPS. Most instruments demonstrated known-group validity.
Differences in the construct validity evidence of the POPS compared with the other 4 instruments were noted. To date, there is no gold standard for measuring participation, and clinicians and researchers should consider the type of information required prior to selecting an instrument.
评价和比较使用国际功能、残疾和健康分类(ICF)开发的 5 种参与工具的结构效度。
共对在急性医院接受诊断和治疗的 545 名脊柱疾病患者进行了随访,并同意完成一份问卷。患者完成了 5 种参与工具(参与和自主影响评估量表(IPA)、基尔参与评估量表(KAP)、参与后急性护理测量量表(PM-PAC)、参与的客观、主观和体验量表(POPS)、世界卫生组织残疾评估量表 II(WHODAS II))。此外,每位患者还完成了一项健康状况量表和一项生活质量量表。评估了参与工具的维度、收敛/区分效度和已知组有效性。
IPA 和 PM-PAC 的因子结构的验证性因子分析表明模型拟合度良好。对于收敛/区分效度,WHODAS II、IPA、KAP 和 PM-PAC 的相似领域之间的相关性通常较高,而预期的是,与 POPS 的客观领域的相关性最低。大多数工具都表现出了已知组有效性。
与其他 4 种工具相比,POPS 的结构效度证据存在差异。迄今为止,还没有衡量参与的黄金标准,临床医生和研究人员在选择工具之前应考虑所需信息的类型。